Invasive group B streptococcal disease in infants: A 19-year nationwide study. Serotype distribution, incidence and recurrent infection

Epidemiology and Infection

Volumn 132, Issue 6, 2004, Pages 1083-1090

  Ekelund, K ^a   Konradsen, H B ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; GENTAMICIN; NETILMICIN; PENICILLIN G;

AGE DISTRIBUTION; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DENMARK; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PULSED FIELD GEL ELECTROPHORESIS; RECURRENT INFECTION; REGISTRATION; SEROTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

DENMARK; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS ANGINOSUS;

EID: 10444263036     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268804002808     Document Type: Article

References (43)

1. Baker CJ, Barrett FF, Gordon RC, Yow MD. Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. J Pediatr 1973; 82: 724-729.
2. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998; 11: 497-513.
3. Simon JL, Bosch J, Puig A, Grau M. Two relapses of group B streptococcal sepsis and transient hypogammaglobulinemia. Pediatr Infect Dis J 1989; 8: 729-730.
4. Moylett EH, Fernandez M, Rench MA, Hickman ME, Baker CJ. A 5-year review of recurrent group B streptococcal disease: lessons from twin infants. Clin Infect Dis 2000; 30: 282-287.
5. Green PA, Singh KV, Murray BE, Baker CJ. Recurrent group B streptococcal infections in infants: clinical and microbiologic aspects. J Pediatr 1994; 125: 931-938.
6. Barton LL, Kapoor NK. Recurrent group B streptococcal infection. Case report. Clin Pediatr (Phila) 1982; 21: 100-101.
7. Siegel JD, Shannon KM, DePasse BM. Recurrent infection associated with penicillin-tolerant group B streptococci: a report of two cases. J Pediatr 1981; 99: 920-924.
8. Broughton DD, Mitchell WG, Grossman M, Hadley WK, Cohen MS. Recurrence of group B streptococcal infection. J Pediatr 1976; 89: 182-185.
9. Ruiz-Gomez D, Tarpay MM, Riley HD. Recurrent group B streptococcal infections: report of three cases. Scand J Infect Dis 1979; 11: 35-38.
10. Denning DW, Bressack M, Troup NJ, Tompkins LS. Infant with two relapses of group B streptococcal sepsis documented by DNA restriction enzyme analysis. Pediatr Infect Dis J 1988; 7: 729-732.
11. Millard DD, Bussey ME, Shulman ST, Yogev R. Multiple group B streptococcal infections in a premature infant: eradication of nasal colonization with rifampin. Am J Dis Child 1985; 139: 964-965.
12. Haque KN, Bashir O, Kambal AM. Delayed recurrence of group B streptococcal infection in a newborn infant: a case report. Ann Trop Paediatr 1986; 6: 219-220.
13. Kenny JF. Recurrent group B streptococcal disease in an infant associated with the ingestion of infected mother's milk. J Pediatr 1977; 91: 158-159.
14. Walker SH, Santos AQ, Quintero BA. Recurrence of group B III streptococcal meningitis. J Pediatr 1976; 89: 187-188.
15. Dorand RD, Adams G. Relapse during penicillin treatment of group B streptococcal meningitis. J Pediatr 1976; 89: 188-190.
16. McCrory JH, Au-Yeung YB, Sugg VM, Chiu TT, Garrison RD. Recurrent group B streptococcal infection in an infant: ventriculitis complicating type Ib meningitis. J Pediatr 1978; 92: 231-233.
17. Lancefield RC. A serological differentiation of specific types of bovine hemolytic streptococci (Group B). J Exp Med 1933; 59 441-458.
18. Slotved HC, Sauer S, Konradsen HB. False-negative results in typing of group B streptococci by the standard Lancefield antigen extraction method. J Clin Microbiol 2002; 40: 1882-1883.
19. Sa-Leao R, Tomasz A, Sanches IS, et al. Genetic diversity and clonal patterns among antibiotic-susceptible and -resistant Streptococcus pneumoniae colonizing children: day care centers as autonomous epidemiological units. J Clin Microbiol 2000; 38: 4137-4144.
20. Petersen JP, Kaltoft MS, Misfeldt J, Schumacher H, Schonheyder HC. A community outbreak of perianal group A streptococcal infection in Denmark. Pediatr Infect Dis J 2002; 22: 105-109.
21. NCCLS. Perfomance standards for antimicrobial susceptibility testing, Twelfth Information Supplement. National Committee for Clinical Laboratory Standards 2002; 22.
22. Swedish Reference Group for Antibiotics (SRGA) (http://www.ltkronoberg.se/ext/raf/raf.htm.). Accessed May 2004.
23. Henriques NB, Novak R, Ortqvist A, Kallenius G, Tuomanen E, Normark S. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis 2001; 32: 552-558.
24. Kalliola S, Vuopio-Varkila J, Takala AK, Eskola J. Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J 1999; 18: 806-810.
25. Harrison LH, Elliott JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. Maryland Emerging Infections Program. J Infect Dis 1998; 177: 998-1002.
26. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15-20.
27. Schuchat A, Whitney C, Zangwill K. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996; 45: 1-25.
28. Schrag SJ, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised Guidelines from CDC. MMWR 2002; 51: 1-22.
29. Obstetric Guidelines 1998. Recommendations for prevention of the neonatal invasive group B streptococcal infections in Denmark [GBS-syndrom (DO236)] (http://home8.inet.tele.dk/uldbjerg/sandbjerg/Sandbjerg.html). Accessed May 2004.
30. Ekelund K, Slotved HC, Nielsen HU, Kaltoft MS, Konradsen HB. Emergence of invasive serotype VIII group B streptococcal infections in Denmark. J Clin Microbiol 2003; 41: 4442-4444.
31. Carstensen H, Henrichsen J, Jepsen OB. A national survey of severe group B streptococcal infections in neonates and young infants in Denmark, 1978-83. Acta Paediatr Scand 1985; 74: 934-941.
32. Hoshina K, Suzuki Y, Nishida H, et al. Trend of neonatal group B streptococcal infection during the last 15 years. Pediatr Int 2002; 44: 641-646.
33. Lin FY, Clemens JD, Azimi PH, et al. Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection. J Infect Dis 1998; 177: 790-792.
34. Baker CJ, Paoletti LC, Wessels MR, et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis 1999; 179: 142-150.
35. Baker CJ, Rench MA, Fernandez M, Paoletti LC, Kasper DL, Edwards MS. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis 2003; 188: 66-73.
36. Harrison LH, Ali A, Dwyer DM, et al. Relapsing invasive group B streptococcal infection in adults. Ann Intern Med 1995; 123: 421-427.
37. Yagupsky P, Menegus MA, Powell KR. The changing spectrum of group B streptococcal disease in infants: an eleven-year experience in a tertiary care hospital. Pediatr Infect Dis J 1991; 10: 801-808.
38. Olver WJ, Bond DW, Boswell TC, Watkin SL. Neonatal group B streptococcal disease associated with infected breast milk. Arch Dis Child Fetal Neonatal Ed 2000; 83: F48-F49.
39. Cunningham R. Recurrent group B streptococcal disease in infants: a possible explanation. Clin Infect Dis 2000; 31: 627.
40. Handwerger S, Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis 1985; 7: 368-386.
41. Fernandez M, Rench MA, Albanyan EA, Edwards MS, Baker CJ. Failure of rifampin to eradicate group B streptococcal colonization in infants. Pediatr Infect Dis J 2001; 20: 371-376.
42. Atkins JT, Heresi GP, Coque TM, Baker CJ. Recurrent group B streptococcal disease in infants: who should receive rifampin? J Pediatr 1998; 132: 537-539.
43. Heath PT, Balfour G, Weisner AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004; 363 292-294.